OGECHIKA EJINDU: Open Payments
NPI 1770228207 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 92 payments from 32 companies in 2025. Trend: 2023 $2,010 · 2024 $3,123 · 2025 $1,895
Food & beverage: $1,895
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $371 |
| Ascendis Pharma Endocrinology Inc | 5 | $202 |
| Lilly USA, LLC | 8 | $146 |
| Amgen Inc. | 5 | $85 |
| BETA BIONICS, INC. | 5 | $78 |
| Antares Pharma, Inc. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Amneal Pharmaceuticals LLC | 4 | $68 |
| Mannkind Corporation | 3 | $65 |
| ABBVIE INC. | 3 | $63 |
Products named: Wegovy, Yorvipath, ZEPBOUND, iLet Bionic Pancreas, XYOSTED, Kerendia, TEPEZZA, UNITHROID.
Industry payments across NC — which companies pay providers there.
